Nursing Elites

1. The client on amiodarone reports shortness of breath. What is the nurse’s best response?

• A. Notify the healthcare provider immediately.
• B. Reassure the client that this is a common side effect.
• C. Instruct the client to monitor their symptoms at home.
• D. Suggest the client reduce physical activity.

Correct answer: A

Rationale: When a client on amiodarone reports shortness of breath, it can be indicative of pulmonary toxicity, a severe side effect associated with this medication. The nurse's priority is to notify the healthcare provider immediately to assess the situation and determine the appropriate course of action. Choice B is incorrect because shortness of breath with amiodarone should not be dismissed as a common side effect. Instructing the client to monitor symptoms at home (Choice C) may delay necessary intervention. Suggesting the client reduce physical activity (Choice D) does not address the potential serious nature of the symptom and the need for prompt evaluation.

2. Which chronic respiratory condition is characterized by the narrowing and inflammation of the airways, leading to difficulty breathing?

• A. Asthma
• B. COPD
• C. Bronchitis
• D. Pneumonia

Correct answer: A

Rationale: Asthma is the correct answer. It is a chronic respiratory condition where the airways become inflamed and narrowed, leading to episodes of wheezing, breathlessness, chest tightness, and coughing. Asthma is characterized by reversible airflow obstruction, differentiating it from COPD, which involves irreversible airflow limitation. Bronchitis is an inflammation of the bronchial tubes without the same reversible airflow obstruction seen in asthma. Pneumonia is an infection of the lung tissue and does not involve chronic inflammation and narrowing of the airways like asthma.

3. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

• A. Increase the dose of warfarin
• B. Administer vitamin K
• C. Monitor for signs of bleeding
• D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

4. The client is on enoxaparin (Lovenox) for DVT prophylaxis. What is the most important lab value to monitor?

• A. Platelet count
• B. PT/INR
• C. aPTT
• D. Hemoglobin

Correct answer: A

Rationale: The correct answer is A: Platelet count. When a client is on enoxaparin (Lovenox), monitoring the platelet count is crucial as enoxaparin can lead to a rare but serious side effect known as heparin-induced thrombocytopenia (HIT), causing a decrease in platelet count. Monitoring the platelet count helps detect this adverse reaction early. Choices B, C, and D are incorrect because enoxaparin therapy does not directly affect PT/INR, aPTT, or hemoglobin levels.

5. Which condition is characterized by the weakening and rupture of the walls of the alveoli in the lungs, reducing the surface area available for gas exchange?

• A. Emphysema
• B. Bronchitis
• C. Atelectasis
• D. Pulmonary fibrosis

Correct answer: A

Rationale: The correct answer is A, Emphysema. Emphysema is a lung condition where the walls of the alveoli become weak and rupture, reducing the surface area available for gas exchange. This leads to shortness of breath. Choice B, Bronchitis, is characterized by inflammation of the bronchial tubes, not the alveoli. Choice C, Atelectasis, involves the collapse of a part or entire lung, not the weakening and rupture of alveolar walls. Choice D, Pulmonary fibrosis, is a condition where lung tissue becomes thickened and stiff, not involving the weakening and rupture of alveoli walls.

Similar Questions